Lv2
180 积分 2024-10-11 加入
Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer
3天前
已完结
Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer
3天前
已完结
Abstract P4-01-16: Overcome chemoresistance of triple-negative breast cancer by inhibiting the RNA-binding protein HuR
4天前
已关闭
Abstract 5959: Therapeutic targeting of HuR using a specific small-molecule inhibitor in triple negative breast cancer
4天前
已关闭
Abstract 1413: Targeting the RNA-binding protein HuR to overcome chemoresistance in triple-negative breast cancer
4天前
已关闭
Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy
4天前
已完结
HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer
4天前
已完结
Abstract 4180: Insights into HuR as a modulator of aerobic glycolysis in triple-negative breast cancer
4天前
已关闭
Reversal chemotherapeutic resistance of triple‐negative breast cancer via functionally inhibiting RNA‐binding protein HuR
4天前
已关闭
Biophysical and molecular characterization of HuR inhibitors, CMLD-2 and Dihydrotanshinone I (DHTS), in Triple Negative Breast Cancer (TNBC)
4天前
已完结
皖公网安备34019202002308
